{"id":3189,"date":"2023-06-01T17:45:00","date_gmt":"2023-06-01T15:45:00","guid":{"rendered":"https:\/\/www.maunakeatech.com\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio-2\/"},"modified":"2024-08-02T12:42:26","modified_gmt":"2024-08-02T10:42:26","slug":"mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio-2","status":"publish","type":"post","link":"https:\/\/www.maunakeatech.com\/int\/news-int\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio-2\/","title":{"rendered":"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae"},"content":{"rendered":"<p style=\"text-align: center;\"><b><i>Study will advance the validation of Cellvizio&reg; as a real-time biopsy guidance tool during robotic-assisted bronchoscopy&nbsp;<\/i><\/b><\/p>\n<p><b>Paris and Boston, June 1<\/b><b>st<\/b><b>, 2023 &ndash; 5:45 PM CEST &ndash; Mauna Kea Technologies <\/b>(Euronext: MKEA) inventor of Cellvizio&reg;, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, today announces that initial enrollment of patients has begun in a prospective, randomized, two-arm, multi-site clinical study sponsored by Mayo Clinic and financially supported by Mauna Kea Technologies. The study will combine nCLE and robotic-assisted bronchoscopy, using both Cellvizio and the Ion platform for minimally invasive peripheral lung biopsy from Intuitive Surgical, Inc., to assess the capability of nCLE to enhance the physician&rsquo;s ability to quickly and accurately position a biopsy tool in the center of peripheral lung nodules (Clinicaltrials.gov: <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05556525\">NCT05556525<\/a>).&nbsp;<\/p>\n<p>The primary objective of this study is to evaluate the ability of nCLE to further improve the diagnostic yield and accuracy of confirming successful targeting of the lesion (&ldquo;tool-in-lesion&rdquo;) and definitive diagnostic sampling of the lesion (&ldquo;lesion-in-tool&rdquo;) during robotic-assisted bronchoscopy procedures. The secondary objectives are to evaluate the reproducibility of using nCLE across multiple facilities and to evaluate the ability of nCLE to diagnose malignancy vs. non-malignancy, including exploring diagnostic yield at the index procedure. This study will include 118 patients with peripheral lung nodules in two U.S. sites, Mayo Clinic&rsquo;s campus in Jacksonville, Florida and Mayo Clinic&rsquo;s campus in Rochester, Minnesota.&nbsp;<\/p>\n<p>&ldquo;The challenges faced by interventional bronchoscopists extend beyond confirming that the needle is in the lesion,&rdquo; said Sacha Loiseau, Chairman and Chief Executive Officer of Mauna Kea Technologies. &ldquo;Once you&rsquo;re in the lesion, it is even more critical to obtain a diagnostic sample, accounting for a number of factors including lesion size, position, and heterogeneity. The combination of Cellvizio and Ion could significantly improve how physicians access and sample small, difficult-to-reach peripheral lesions, creating a profound impact on patient outcomes.&rdquo;&nbsp;<\/p>\n<p><\/p>\n<div id=\"old_link\"><a href=\"https:\/\/cdn.maunakeatech.com\/en\/media\/download\/3535\">READ THE COMPLETE PRESS RELEASE<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Study will advance the validation of Cellvizio&reg; as a real-time biopsy guidance tool during robotic-assisted bronchoscopy&nbsp; Paris and Boston, June 1st, 2023 &ndash; 5:45 PM CEST &ndash; Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio&reg;, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, today announces that initial enrollment of patients has begun in [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":3190,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[34],"tags":[],"class_list":["post-3189","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-int"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae - Mauna Kea Technologies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae - Mauna Kea Technologies\" \/>\n<meta property=\"og:description\" content=\"Study will advance the validation of Cellvizio&reg; as a real-time biopsy guidance tool during robotic-assisted bronchoscopy&nbsp; Paris and Boston, June 1st, 2023 &ndash; 5:45 PM CEST &ndash; Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio&reg;, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, today announces that initial enrollment of patients has begun in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/\" \/>\n<meta property=\"og:site_name\" content=\"Mauna Kea Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/maunakeatech\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-01T15:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-02T10:42:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"192\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Zina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:site\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Zina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/\"},\"author\":{\"name\":\"Zina\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/f7b9fab57af781ddbbb4933c3f16a4ac\"},\"headline\":\"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae\",\"datePublished\":\"2023-06-01T15:45:00+00:00\",\"dateModified\":\"2024-08-02T10:42:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/\"},\"wordCount\":353,\"image\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"int\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/\",\"name\":\"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae - Mauna Kea Technologies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\",\"datePublished\":\"2023-06-01T15:45:00+00:00\",\"dateModified\":\"2024-08-02T10:42:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/f7b9fab57af781ddbbb4933c3f16a4ac\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/#breadcrumb\"},\"inLanguage\":\"int\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\",\"contentUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png\",\"width\":330,\"height\":192},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/news\\\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.maunakeatech.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#website\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/\",\"name\":\"Mauna Kea Technologies\",\"description\":\"See Cells. Change Lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.maunakeatech.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"int\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/f7b9fab57af781ddbbb4933c3f16a4ac\",\"name\":\"Zina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"int\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"caption\":\"Zina\"},\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/int\\\/author\\\/zina\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae - Mauna Kea Technologies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/","og_locale":"en_US","og_type":"article","og_title":"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae - Mauna Kea Technologies","og_description":"Study will advance the validation of Cellvizio&reg; as a real-time biopsy guidance tool during robotic-assisted bronchoscopy&nbsp; Paris and Boston, June 1st, 2023 &ndash; 5:45 PM CEST &ndash; Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio&reg;, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p\/nCLE) platform, today announces that initial enrollment of patients has begun in [&hellip;]","og_url":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/","og_site_name":"Mauna Kea Technologies","article_publisher":"https:\/\/www.facebook.com\/maunakeatech\/","article_published_time":"2023-06-01T15:45:00+00:00","article_modified_time":"2024-08-02T10:42:26+00:00","og_image":[{"width":330,"height":192,"url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","type":"image\/png"}],"author":"Zina","twitter_card":"summary_large_image","twitter_creator":"@maunakeatech","twitter_site":"@maunakeatech","twitter_misc":{"Written by":"Zina","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/#article","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/"},"author":{"name":"Zina","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac"},"headline":"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae","datePublished":"2023-06-01T15:45:00+00:00","dateModified":"2024-08-02T10:42:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/"},"wordCount":353,"image":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","articleSection":["News"],"inLanguage":"int"},{"@type":"WebPage","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/","url":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/","name":"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae - Mauna Kea Technologies","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/#primaryimage"},"image":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","datePublished":"2023-06-01T15:45:00+00:00","dateModified":"2024-08-02T10:42:26+00:00","author":{"@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac"},"breadcrumb":{"@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/#breadcrumb"},"inLanguage":"int","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/"]}]},{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/#primaryimage","url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","contentUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/80321e3cb153c39f1bbbc885b2ccaae176cc7e05.png","width":330,"height":192},{"@type":"BreadcrumbList","@id":"https:\/\/www.maunakeatech.com\/news\/mauna-kea-technologies-announces-start-of-enrollment-in-peripheral-lung-cancer-multi-site-clinical-trial-combining-ion-with-cellvizio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.maunakeatech.com\/"},{"@type":"ListItem","position":2,"name":"Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion\u00ae with Cellvizio\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.maunakeatech.com\/#website","url":"https:\/\/www.maunakeatech.com\/","name":"Mauna Kea Technologies","description":"See Cells. Change Lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.maunakeatech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"int"},{"@type":"Person","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac","name":"Zina","image":{"@type":"ImageObject","inLanguage":"int","@id":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","caption":"Zina"},"url":"https:\/\/www.maunakeatech.com\/int\/author\/zina\/"}]}},"_links":{"self":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/3189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/comments?post=3189"}],"version-history":[{"count":1,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/3189\/revisions"}],"predecessor-version":[{"id":5522,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/posts\/3189\/revisions\/5522"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media\/3190"}],"wp:attachment":[{"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/media?parent=3189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/categories?post=3189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/int\/wp-json\/wp\/v2\/tags?post=3189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}